Universal HBV screening in China is cost-effective, the earlier the better

A/Prof Lei Zhang is senior author on a paper modelling early
diagnostic screening for HBV infection in China

China has one of the largest disease burdens of hepatitis B virus (HBV) infections worldwide, accounting for one-third of the world's infected population. If uncontrolled, chronic HBV infection can lead to liver cirrhosis and liver cancer. 

However, estimated only 19% of chronic HBV-infected people are diagnosed in China, versus the 90% target set by the WHO for HBV elimination by 2030. A universal HBV screening program may improve diagnostic rates and aid China in reaching the WHO 2030 target.